Profil
Ulf Thomas Blom was the founder of Enzymatica AB, founded in 2007, where the title held was Executive Vice President-Marketing & Operations from 2014 to 2021.
Current jobs include Chief Executive Officer & Director at Medzyme Invest öresund AB, Director at Enzymatica Care AB, Independent Director at Pharmiva AB since 2020, and Director at Meminisse Process AB. Former job includes Director at Idogen AB. Education includes an MBA from Lund University School of Economics & Management.
Postes actifs de Ulf Thomas Blom
| Sociétés | Poste | Début |
|---|---|---|
| PHARMIVA AB (PUBL) | Directeur/Membre du Conseil | 01/01/2020 |
Enzymatica Care AB | Directeur/Membre du Conseil | - |
Medzyme Invest öresund AB | Directeur Général | - |
Meminisse Process AB | Directeur/Membre du Conseil | - |
Anciens postes connus de Ulf Thomas Blom
| Sociétés | Poste | Fin |
|---|---|---|
Idogen AB
Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Directeur/Membre du Conseil | - |
| ENZYMATICA AB | Fondateur | - |
Formation de Ulf Thomas Blom
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Enzymatica AB
Enzymatica AB Medical SpecialtiesHealth Technology Develops and sells medical technology products against infectious diseases | Health Technology |
Idogen AB
Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases | Health Technology |
Lund University School of Economics & Management
Lund University School of Economics & Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enzymatica Care AB | |
Medzyme Invest öresund AB | |
Pharmiva AB
Pharmiva AB Miscellaneous Commercial ServicesCommercial Services Provides scientific research and development services | Commercial Services |
Meminisse Process AB |
















